← Open Payments lookup

CLAIRE EXUM: Open Payments

NPI 1053952648 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$985 in 48 payments from 16 companies in 2025. Trend: 2023 $1,310 · 2024 $1,408 · 2025 $985

Food & beverage: $937Education: $48
CompanyPaymentsAmount
PFIZER INC.14$177
AstraZeneca Pharmaceuticals LP6$172
GlaxoSmithKline, LLC.5$113
Novo Nordisk Inc5$107
Madrigal Pharmaceuticals2$58
Corcept Therapeutics3$50
Otsuka America Pharmaceutical, Inc.2$45
Aimmune Therapeutics, Inc.2$42
Merck Sharp & Dohme LLC1$41
Amgen Inc.2$39

Products named: ELIQUIS, AIRSUPRA, Ozempic, TRELEGY ELLIPTA, BREZTRI, REZDIFFRA, Korlym, REXULTI.

Industry payments across KS — which companies pay providers there.